公司概覽
業務類別 Drug Manufacturers - General
業務概覽 Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
公司地址 Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
電話號碼 +1 609 252-4621
傳真號碼 --
公司網頁 https://www.bms.com
員工數量 32500
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Phil Holzer Senior Vice President, Principal Accounting Officer and Controller -- 11/02/2026
Ms. Sandra Leung Executive Vice President and General Counsel 美元 1.15M 18/02/2025
Mr. David V. Elkins Executive Vice President and Chief Financial Officer 美元 1.12M 11/02/2026
Dr. Christopher S. Boerner, PhD Chairman of the Board and Chief Executive Officer 美元 1.54M 11/02/2026
Mr. Adam Lenkowsky Executive Vice President and Chief Commercialization Officer -- 11/02/2026
Dr. Cristian Massacesi, M.D. Executive Vice President, Chief Medical Officer and Head of Development -- 11/02/2026
Mr. Hiroshi Chris Shibutani, M.D. Executive Vice President and Chief Strategy Officer -- 11/02/2026
Mr. Benjamin J. Hickey, M.B.A. President, RayzeBio Organization -- 11/02/2026
Ms. Amanda Ahn Poole Executive Vice President and Chief People Officer -- 11/02/2026
Ms. Cari Gallman Executive Vice President, General Counsel and Chief Policy Officer -- 11/02/2026
Ms. Wendy Short Bartie Executive Vice President, Corporate Affairs -- 11/02/2026
Ms. Lynelle Hoch President, Cell Therapy Organization -- 11/02/2026
Ms. Karin Shanahan Executive Vice President, Chief Supply Chain and Operations 美元 1.01M 11/02/2026
Dr. Robert M. Plenge, M.D.,PhD Executive Vice President, Chief Research Officer and Head of Research -- 11/02/2026
Mr. Gregory Scott Meyers Executive Vice President, Chief Digital Officer and Chief Technology Officer -- 11/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Derica W. Rice Independent Director 11/02/2026
Ms. Phyllis R. Yale Independent Director 11/02/2026
Ms. Paula A. Price Independent Director 11/02/2026
Mr. Peter J. Arduini Independent Director 11/02/2026
Dr. Christopher S. Boerner, PhD Chairman of the Board and Chief Executive Officer 11/02/2026
Dr. Julia A. Haller, M.D. Independent Director 11/02/2026
Mr. Theodore R. Samuels Lead Independent Director 11/02/2026
Dr. Karen H. Vousden, PhD Independent Director 11/02/2026
Dr. Manuel Hidalgo Medina, M.D.,PhD Independent Director 11/02/2026
Mr. Michael R. McMullen Independent Director 11/02/2026
Dr. Deepak L. Bhatt, M.B.A.,M.D.,M.P.H. Independent Director 11/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:37)
代號 名稱 佔比% 持有日期
USMFWisdomTree US Multifactor0.001%27/02/2026
HIDVAB US High Dividend ETF0.001%27/02/2026
XVViShares ESG Select Screened S&P 500 ETF0.001%28/02/2026
VLUState Street® SPDR® S&P® 1500 ValTiltETF0.001%27/02/2026
SFYSoFi Select 500 ETF0.001%27/02/2026
CFAVictoryShares US 500 Volatility Wtd ETF0.001%27/02/2026
JPUSJPMorgan Diversified Return US Eq ETF0.001%27/02/2026
RXLProShares Ultra Health Care0.001%27/02/2026
GNOMGlobal X Genomics & Biotechnology ETF0.001%27/02/2026
PFDEPathfinder Disciplined US Equity ETF0.001%27/02/2026
GVUSGoldman Sachs MktBt Russell LgCpValEqETF0.001%27/02/2026
DEWWisdomTree Global High Dividend ETF0.001%27/02/2026
LSTLeuthold Select Industries ETF0.001%27/02/2026
IQSUNYLI Candriam U.S. Large Cap Equity ETF0.001%27/02/2026
GVLUGotham 1000 Value ETF0.001%27/02/2026
DXUVDimensional US Vector Equity ETF0.001%27/02/2026
FYEEFidelity Yield Enhanced Equity ETF0.001%27/02/2026
RSPAInvesco S&P 500 Eq Wght Inc Adv ETF0.001%27/02/2026
JUSTGoldman Sachs JUST US Large Cap Eq ETF0.001%27/02/2026
KOKUXtrackers MSCI Kokusai Equity ETF0.001%24/02/2026
  1    2    3    4    5    6    7    8    9    10    11   12    13    14    15    16    17    18    19    20    21    22  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.